March 1, 2022 | Market Access, oncology
Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies
With CAR-Ts continuing to take centre stage as a paradigm shift in the treatment of cancer, Tania Rodrigues investigates how market access and hospital processes will need to transform to accommodate the influx of these innovative therapies.
Download the white paper here: https://bit.ly/36T8d5j
This content was provided by Inizio
Latest Content from Inizio
Published in eyeforpharma April 2016 by Rachel Howard
Within the pharmaceutical industry, there is an increasing need for market research teams to share the insights with their key internal stakeholders, from marketing and brand managers to sales reps…
Research Partnership is delighted to announce promotions and new starters in the UK and further appointments in the US and Singapore offices
In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy…
In emerging markets where primary care systems do not exist, the patient is the only constant in the journey
Pegasus, one of the most successful integrated healthcare communications consultancies in the UK, has today announced it has been acquired by UDG Healthcare plc, a FTSE 250 listed international provider…
Are you looking for a deeper understanding of the emotional needs, behaviours and treatment programmes of patients living with Crohn’s Disease?
Our latest infographic offers an overview of some key facts and figures about the company, its services and capabilities.
Therapy Watch recently presented “real-world” patient data on treatment duration and persistence among European PsO patients
Research director of Therapy Watch, Laurent Chanroux, discusses the growth opportunities for biosimilars and the importance of adaptable market tracking for pre and post product launch
